[
    "6/04/PCTCN2022113490-appb-000186.tif\"/></p>Compound R81-1 (100mg), N-methyl-1H-benzo[d]imidazol-2-amine (84mg), BinAP (48mg), Pd(OAc) <sub>2</sub> (18mg), potassium phosphate (74mg) in 1 , Stir and dissolve 4-dioxane, react at 100\u00b0C for 12 hours under the protection of N <sub>2</sub> , after TLC detects that the reaction is complete, concentrate the solvent under reduced pressure, add water to the residue, extract twice with ethyl acetate, dry the acetic acid with anhydrous sodium sulfate The ethyl ester phase was concentrated and purified by column chromatography (petroleum ether:ethyl acetate=1:1-1:4) to obtain compound R81 (26 mg, 20%) as a white solid. <sup>1</sup> H NMR (400MHz, DMSO) \u03b49.31(s, 1H), 8.61(s, 1H), 8.21(s, 1H), 7.27(d, 1H), 7.11(t, 1H), 7.01(t, 1H ), 4.99\u20134.52(m, 2H), 4.17(d, 2H), 3.81(t, 2H), 3.65(t, 1H), 3.12(d, 3H), 1.72(s, 2H), 1.43(d, 5H), 1.27(s, 3H). LC-MS [M+H] <sup>+</sup> = 483.</p>The synthesis of embodiment 46 compound R82</p><img id=\"\" path=\"PCTCN2022113490-appb-000187.tif\" file=\"https://surechembl.org/api/assets/attachment/1030879267/WO/20230223/A1/002023/02/06/04/PCTCN2022113490-appb-000187.tif\"/></p>(1) Step 1:</p><img id=\"\" path=\"PCTCN2022113490-appb-000188.tif\" file=\"https://surechembl.org/api/assets/attachment/1030879270/WO/20230223/A1/002023/02/06/04/PCTCN2022113490-appb-000188.tif\"/></p>(R)-4-(6-chloro-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-methylmorpholine (200mg) and bromocyclopentane (234mg), CS <sub>2</sub> CO <sub>3</sub> (515 mg) and KI (40 mg) were refluxed in DMF and stirred overnight. After the reaction was complete as detected by TLC, dilute with water, add ethyl acetate for extraction twice, separate the liquids, wash the ethyl acetate phase with saturated saline once, It was dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated under reduced pressure, and purified by column chromatography (petroleum ether: ethyl acetate = 1:1) to obtain compound R82-1 (230 mg, 89%) as an oil. LC-MS [M+H] <sup>+</sup> =322.</p>(2) Step 2:</p><img id=\"\" path=\"PCTCN2022113490-appb-000189.tif\" file=\"https://surechembl.org/api/assets/attachment/1030879272/WO/20230223/A1/002023/02/06/04/PCTCN2022113490-appb-000189.tif\"/></p>Compound R82-1 (160mg), N-methyl-1H-benzo[d]imidazol-2-amine (84mg), BinAP (58mg), Pd(OAc) <sub>2</sub> (58mg), potassium phosphate (129mg) in 1 , Stir and dissolve 4-dioxane, react at 100\u00b0C for 12 hours under the protection of N <sub>2</sub> , after TLC detects that the reaction is complete, concentrate the solvent under reduced pressure, add water to the residue, extract twice with ethyl acetate, dry the acetic acid with anhydrous sodium sulfate The ethyl ester phase was concentrated and purified by column chromatography (petroleum ether:ethyl acetate=1:1-1:4) to obtain compound R82 (16 mg, 7.2%) as a white solid. <sup>1</sup> H NMR (400MHz, DMSO) \u03b48.18(s, 1H), 7.54\u20137.42(m, 3H), 7.15\u20137.04(m, 2H), 5.34(t, 1H), 4.67(s, 2H), 4.51 \u20134.30(m, 2H), 4.02(d, 1H), 3.81(s, 3H), 3.72(dd, 1H"
]